Paracetamol

Producers shown on SFDA

(Record date:31/08/2021）

Producers shown on EP

(Quoted from EP website；record date:31/08/2021）

Producer:Shenzhou branch of Hebei Jiheng (Group) Pharmaceutical Co., Ltd. has been cancelled.

Hebei Jiheng (Group) Pharmaceutical Co., Ltd., established in 1996, is a wholly-owned subsidiary of Hebei Jiheng group.

The company strictly implements GMP standards. Its leading products paracetamol, analgin and folic acid have obtained national GMP certificate, kosher certificate, Indian registration certificate and American DMF registration number. Now they are being certified by American FDA. The pillar product paracetamol has obtained the EU cos certificate; Folic acid has obtained halal certificate. The company has the right to import and export products. Its products are sold to 30 provinces, cities and autonomous regions in China and more than 40 countries and regions such as the Middle East, Southeast Asia, South America, Eastern Europe and Africa, and enjoy a good reputation at home and abroad.

Registered capital:/

Producer:Novartis (Wuxi) Pharmaceutical Co., Ltd. (formerly Rodia Wuxi Pharmaceutical Co., Ltd.) is a wholly-owned subsidiary of novacyl, France. It was established in 2001 and mainly produces powder, particles and other pharmaceutical intermediates of raw drug p-acetaminophen. The company is located at No. 8, Guangshi West Road, Wuxi City, covering an area of about 40000 square meters and a construction area of about 14000 square meters. The plant is reasonably arranged according to GMP requirements. The company is a cooperative supplier of raw material drug p-aminophenol powder, particles and other pharmaceutical intermediates for many top pharmaceutical companies in the world.

Registered capital:USD 16.8 million

Producer:Tianjin Bofa Pharmaceutical Co., Ltd. is a manufacturer of paracetamol API. It was established in April 2004, formerly known as Hongfa branch of Xinxin Pharmaceutical Factory of Tianjin Zhongxin Pharmaceutical Group Co., Ltd.

In July 2004, it passed the GMP certification of Tianjin drug administration. The registered capital is 3 million yuan. The annual output reaches 9000 tons. In 2009, it created brilliance again, and passed the GMP certification again by Tianjin drug administration on June 18, 2009, with an annual output of 10000 tons. It has become a leading enterprise with high quality, high standard and high output value.

Registered capital:RMB 10 million

Producer:Anqiu Lu'an Pharmaceutical Co., Ltd. (formerly Weifang No. 4 pharmaceutical factory) is a manufacturer of Western medicine raw materials. The company mainly produces and exports western medicine raw material paracetamol, with an annual production capacity of 40000 tons  、 The annual production capacity of DC grade paracetamol is 12000 tons  ； Paracetamol solid preparation is 8 billion tablets / capsule, and the products sell well in more than 100 countries and regions around the world   。 Become the world's largest paracetamol production base.   The company's products have passed the US FDA quality certification, EU EDQM certification and the quality audit of the Canadian government for five consecutive times. The product paracetamol has obtained the applicability certificate of European Pharmacopoeia issued by the European Medical Quality Council.

Registered capital:RMB 60 million

Producer:Lianyungang Kangle Pharmaceutical Co., Ltd. is a newly completed and put into operation API production enterprise. The company is located in Ganyu District Economic Development Zone, Lianyungang City, covering an area of more than 80000 square meters, a construction area of nearly 20000 square meters, with a total investment of 80 million yuan. The selected production equipment has reached the international and domestic advanced level, with first-class laboratory instruments and testing equipment and a team with high education High quality management team and staff were officially put into production in November 2004. The company's main products are acetaminophen (paracetamol), the raw material drug. The products are mainly exported to Nigeria, Indonesia, South Korea, Taiwan, Singapore, Hong Kong and many other countries and regions. As a newly-built drug manufacturer, it has a production line established in full accordance with cGMP standards and advanced testing equipment, with an annual production of 6000 tons of acetaminophen (paracetamol).

Registered capital:RMB 20 million

Producer:Hebei Jiheng (Group) Pharmaceutical Co., Ltd., established in 1996, is a wholly-owned subsidiary of Hebei Jiheng group.

The company strictly implements GMP standards. Its leading products paracetamol, analgin and folic acid have obtained national GMP certificate, kosher certificate, Indian registration certificate and American DMF registration number. Now they are being certified by American FDA. The pillar product paracetamol has obtained the EU cos certificate; Folic acid has obtained halal certificate. The company has the right to import and export products. Its products are sold to 30 provinces, cities and autonomous regions in China and more than 40 countries and regions such as the Middle East, Southeast Asia, South America, Eastern Europe and Africa, and enjoy a good reputation at home and abroad.

Staff size:900-999 people

Producer:Anhui BBAC Likang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of BBCA Pharmaceutical , was established in November 2010 with a registered capital of 66 million yuan. It is mainly engaged in the production and sales of APIs and the import and export of its products and technologies. The company is located in Bengbu high tech Development Zone, covering an area of about 135 mu.

At present, the company has an annual production capacity of 8000 tons of paracetamol and 2000 tons of dc90. The product quality meets the requirements of Chinese Pharmacopoeia (cp2010), European Pharmacopoeia (EP7) and American Pharmacopoeia (usp36), and has been highly praised by customers in domestic and foreign markets.

 Staff size:200-299 people

Registered capital:RMB 138 million

Producer:Jiuquan Dadeli Pharmaceutical Co., Ltd., a holding subsidiary of Lanzhou Dadeli Pharmaceutical Group, is a high-tech enterprise specializing in drug R & D, production and sales. There are 146 drug approval numbers, including 32 API approvals. The company has more than ten production lines for solid preparations, small volume injections, lyophilized powder injections, biochemical APIs, chemical APIs, traditional Chinese medicine extraction, traditional Chinese medicine decoction pieces, etc., all of which have passed the national GMP certification.

Staff size:100-199 people

Registered capital:RMB 59.43 million

Producer:Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd. (formerly Shantou Jinshi Pharmaceutical General Factory) is now a wholly-owned subsidiary of Shanghai Modern Pharmaceutical Co., Ltd.

The enterprise covers an area of more than 36 Mu and a construction area of more than 20000 square meters. Its production scope includes chemical APIs, sterile APIs, tablets, hard capsules, powder injections, granules, dry suspensions, oral liquids and oral solutions. It has independently developed, developed and produced 154 approvals, including 142 preparations and 12 APIs; The Department and all its production lines (nine dosage forms and seven workshops in total) have passed the new version of GMP certification.

Staff size:400-499 people

Registered capital:RMB 83.98 million

Producer:Liaoyuan Baikang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Chongqing Sansheng Industrial Co., Ltd. Its predecessor, Liaoyuan No. 1 pharmaceutical factory, was founded in 1958.

After more than 50 years of accumulation and development, the company now has 104 drug production approval numbers, including 20 APIs and 84 preparations. The leading varieties of API are acetaminophen, chlorpipetin hydrochloride, nefopam hydrochloride, procaine hydrochloride, diphenhydramine hydrochloride, famotidine, dioxpromazine hydrochloride and levofloxacin mesylate. The annual output of preparations is more than 2 billion tablets, mainly including chlorpipetin hydrochloride tablets and compound paracetamol diphenhydramine tablets. The company has import and export rights, and its products are mainly exported to India, Hong Kong, Macao, Taiwan and other countries and regions. The company has passed GMP certification and COS certification, and is applying for FDA certification to obtain a pass for products to enter the European and American markets.

Staff size:About 400 people

Registered capital:RMB 50 million 

Producer:Huazhong Pharmaceutical Co., Ltd. is subordinate to China Ordnance Equipment Group Corporation. It is located in Xiangyang City, an important town in Northwest Hubei Province with beautiful scenery and rich resources. It covers an area of 700000 square meters. It is a modern comprehensive pharmaceutical enterprise integrating R & D, production and sales of pharmaceutical products. The company has strong technical force, complete quality testing equipment and quality assurance system, advanced production technology and equipment, and has passed GMP, fami-qs, HACCP, ISO9001, ISO22000, kosher, halal and other certifications.

Subsidiaries of Huazhong Pharmaceutical Co., Ltd.: Hubei 295 Technology Co., Ltd. and Xiangfan 295 Pharmaceutical Trading Co., Ltd. We are the earliest manufacturer of vitamin B1 raw materials in China and the largest in the world. The product quality meets the quality standards of CP, BP, USP, EP and JP. At the same time, we have also developed VB1 Granule Series and VB1 derivative series products.

Staff size:600-699 people

Registered capital:RMB 245 million 148 thousand and 515

Producer:Changshu Huagang Pharmaceutical Co., Ltd., founded in 1991, is a manufacturer of Western medicine raw materials, covering an area of more than 100000 square meters. It has been renamed Changshu Huayu Trading Co., Ltd.

The company mainly produces and exports paracetamol (paracetamol), the raw material of Western medicine, with an annual output of 8000 tons; Paracetamol dc90%. In 2004, it passed the national GMP certification and obtained the GMP certificate. In 2007, it passed the EDQM European GMP on-site verification. In 2008, he obtained the cos certificate and carried out DMF registration and FDA certification in the United States. The product paracetamol obtained the cos certificate issued by EDQM in 2008. The products are exported all over the world with good reputation and class a quality. At present, the company has completed DMF registration in the United States and FDA certification is in progress.

Staff size:About 50 people

Registered capital:USD 1 million 889 thousand and 100

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978